Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Cash from Financing Activities: 2011-2025

Historic Cash from Financing Activities for Catalyst Pharmaceuticals (CPRX) over the last 11 years, with Sep 2025 value amounting to $4.7 million.

  • Catalyst Pharmaceuticals' Cash from Financing Activities rose 177.90% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 million, marking a year-over-year decrease of 90.40%. This contributed to the annual value of $140.7 million for FY2024, which is 1395.62% up from last year.
  • As of Q3 2025, Catalyst Pharmaceuticals' Cash from Financing Activities stood at $4.7 million, which was up 433.72% from $872,000 recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Cash from Financing Activities registered a high of $141.0 million during Q1 2024, and its lowest value of -$10.1 million during Q3 2023.
  • In the last 3 years, Catalyst Pharmaceuticals' Cash from Financing Activities had a median value of $872,000 in 2025 and averaged $12.6 million.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Cash from Financing Activities crashed by 10,397.22% in 2021 and then surged by 94,563.76% in 2024.
  • Over the past 5 years, Catalyst Pharmaceuticals' Cash from Financing Activities (Quarterly) stood at -$2.5 million in 2021, then skyrocketed by 189.19% to $2.3 million in 2022, then slumped by 129.52% to -$665,000 in 2023, then soared by 766.62% to $4.4 million in 2024, then spiked by 177.90% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, $872,000 for Q2 2025, and $3.1 million during Q1 2025.